Half-year report · HY
4361.TEDINET S100YP26
Period2025-12-01 → 2026-05-31
Filed2026-07-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.3bn | 2025-12-01 → 2026-05-31 | Cons. | Net sales |
| Revenue | ¥8.8bn | 2024-12-01 → 2025-11-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥4.3bn | 2024-12-01 → 2025-05-31 | Cons. | Net sales |
| Operating income | ¥304m | 2025-12-01 → 2026-05-31 | Cons. | Operating income |
| Operating income | ¥199m | 2024-12-01 → 2025-05-31 | Cons. | Operating income |
| Ordinary income | ¥285m | 2025-12-01 → 2026-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥405m | 2024-12-01 → 2025-11-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥183m | 2024-12-01 → 2025-05-31 | Cons. | Ordinary income |
| Profit before tax | ¥288m | 2025-12-01 → 2026-05-31 | Cons. | Income before income taxes |
| Profit before tax | ¥183m | 2024-12-01 → 2025-05-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥209m | 2025-12-01 → 2026-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥298m | 2024-12-01 → 2025-11-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥135m | 2024-12-01 → 2025-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥209m | 2025-12-01 → 2026-05-31 | Cons. | Profit loss |
| Net income | ¥135m | 2024-12-01 → 2025-05-31 | Cons. | Profit loss |
| Total assets | ¥9.0bn | at 2026-05-31 | Cons. | Assets |
| Total assets | ¥8.9bn | at 2025-11-30 | Cons. | Assets |
| Total assets | ¥8.8bn | at 2025-05-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥5.7bn | at 2026-05-31 | Cons. | Liabilities |
| Total liabilities | ¥5.7bn | at 2025-11-30 | Cons. | Liabilities |
| Net assets / equity | ¥3.3bn | at 2026-05-31 | Cons. | Net assets |
| Net assets / equity | ¥3.1bn | at 2025-11-30 | Cons. | Net assets |
| Net assets / equity | ¥2.9bn | at 2025-05-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.0bn | at 2026-05-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.2bn | at 2025-11-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.0bn | at 2026-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.2bn | at 2025-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.3bn | at 2025-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥745m | at 2024-11-30v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.1bn | 2025-12-01 → 2026-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥830m | 2024-12-01 → 2025-11-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥566m | 2024-12-01 → 2025-05-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥138m | 2025-12-01 → 2026-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥739m | 2024-12-01 → 2025-11-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥216m | 2024-12-01 → 2025-05-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥228m | 2025-12-01 → 2026-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥360m | 2024-12-01 → 2025-11-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥187m | 2024-12-01 → 2025-05-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥171.92 | 2025-12-01 → 2026-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥245.11 | 2024-12-01 → 2025-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥110.52 | 2024-12-01 → 2025-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 36.6% | at 2026-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 35.3% | at 2025-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.5% | at 2025-05-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 18
| Segment | Item | Period | Value |
|---|---|---|---|
| Pharmaceutical Productsreportable segment | revenue | 2025-12-01 → 2026-05-31 | ¥4.3bn |
| Pharmaceutical Productsreportable segment | revenue external | 2025-12-01 → 2026-05-31 | ¥4.3bn |
| Pharmaceutical Productsreportable segment | segment profit | 2025-12-01 → 2026-05-31 | ¥288m |
| Real Estate Leasingreportable segment | revenue | 2025-12-01 → 2026-05-31 | ¥19m |
| Real Estate Leasingreportable segment | revenue external | 2025-12-01 → 2026-05-31 | ¥19m |
| Real Estate Leasingreportable segment | segment profit | 2025-12-01 → 2026-05-31 | ¥15m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-12-01 → 2026-05-31 | ¥4.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-12-01 → 2026-05-31 | ¥4.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-12-01 → 2026-05-31 | ¥304m |
| Pharmaceutical Productsreportable segment | revenue | 2024-12-01 → 2025-05-31 | ¥4.3bn |
| Pharmaceutical Productsreportable segment | revenue external | 2024-12-01 → 2025-05-31 | ¥4.3bn |
| Pharmaceutical Productsreportable segment | segment profit | 2024-12-01 → 2025-05-31 | ¥184m |
| Real Estate Leasingreportable segment | revenue | 2024-12-01 → 2025-05-31 | ¥19m |
| Real Estate Leasingreportable segment | revenue external | 2024-12-01 → 2025-05-31 | ¥19m |
| Real Estate Leasingreportable segment | segment profit | 2024-12-01 → 2025-05-31 | ¥15m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-12-01 → 2025-05-31 | ¥4.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-12-01 → 2025-05-31 | ¥4.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-12-01 → 2025-05-31 | ¥199m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 480
| Item | Context | Value | Unit |
|---|---|---|---|
| Other ncl | Prior1YearInstant | 101012000 | JPY |
| Other ncl | InterimInstant | 127689000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 1458234000 | JPY |
| Noncurrent liabilities | InterimInstant | 1299065000 | JPY |
| Liabilities | Prior1YearInstant | 5734568000 | JPY |
| Liabilities | InterimInstant | 5718615000 | JPY |
| Capital stock | Prior1YearInstant | 610000000 | JPY |
| Capital stock | InterimInstant | 610000000 | JPY |
| Capital surplus | Prior1YearInstant | 58437000 | JPY |
| Capital surplus | InterimInstant | 58437000 | JPY |
| Retained earnings | Prior1YearInstant | 2381849000 | JPY |
| Retained earnings | InterimInstant | 2518101000 | JPY |
| Treasury stock | Prior1YearInstant | -8368000 | JPY |
| Treasury stock | InterimInstant | -8368000 | JPY |
| Shareholders equity | Prior1YearInstant | 3041918000 | JPY |
| Shareholders equity | InterimInstant | 3178170000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 22695000 | JPY |
| Valuation difference on available for sale securities | InterimInstant | 30253000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 68899000 | JPY |
| Foreign currency translation adjustment | InterimInstant | 87184000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 91594000 | JPY |
| Valuation and translation adjustments | InterimInstant | 117437000 | JPY |
| Net assets | Prior1YearInstant | 3133512000 | JPY |
| Net assets | InterimInstant | 3295608000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 8868081000 | JPY |
| Liabilities and net assets | InterimInstant | 9014224000 | JPY |
| Net sales | Prior1InterimDuration | 4314059000 | JPY |
| Net sales | InterimDuration | 4315008000 | JPY |
| Cost of sales | Prior1InterimDuration | 3512767000 | JPY |
| Cost of sales | InterimDuration | 3412230000 | JPY |
| Gross profit | Prior1InterimDuration | 801292000 | JPY |
| Gross profit | InterimDuration | 902777000 | JPY |
| Selling general and administrative expenses | Prior1InterimDuration | 602343000 | JPY |
| Selling general and administrative expenses | InterimDuration | 598961000 | JPY |
| Operating income | Prior1InterimDuration | 198948000 | JPY |
| Operating income | InterimDuration | 303815000 | JPY |
| Interest income noi | Prior1InterimDuration | 1822000 | JPY |
| Interest income noi | InterimDuration | 1702000 | JPY |
| Dividends income noi | Prior1InterimDuration | 1134000 | JPY |
| Dividends income noi | InterimDuration | 1412000 | JPY |
| Reversal of allowance for doubtful accounts noi | Prior1InterimDuration | 631000 | JPY |
| Reversal of allowance for doubtful accounts noi | InterimDuration | 1936000 | JPY |
| Other noi | Prior1InterimDuration | 4302000 | JPY |
| Other noi | InterimDuration | 2330000 | JPY |
| Non operating income | Prior1InterimDuration | 7890000 | JPY |
| Non operating income | InterimDuration | 7382000 | JPY |
| Interest expenses noe | Prior1InterimDuration | 17025000 | JPY |
| Interest expenses noe | InterimDuration | 23538000 | JPY |
| Foreign exchange losses noe | Prior1InterimDuration | 6408000 | JPY |
| Foreign exchange losses noe | InterimDuration | 2239000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |